What 2027’s workplace equality reforms mean for life sciences hiring

UK life sciences employers are heading into a year of significant change in employment law. On 8 January 2027, the Westminster Employment Forum will hold a policy conference examining the next phase of workplace equality reform affecting women, covering the Employment Rights Act 2025, equal pay and transparency, harassment prevention, women’s health at work and progression into leadership.

The conference is a forum for discussion rather than a policy announcement, and much of the detail is still being worked through. But the agenda brings together the measures that hiring managers will need to plan around, and several of them land directly on how life sciences teams recruit, retain and progress their people.

A tighter window for hiring decisions

The unfair dismissal qualifying period reduces to six months for dismissals from 1 January 2027, and the agenda also points to tribunal time limits extending to six months. Together, these shorten the period in which an employer can part ways with a new starter without facing a potential claim.

For hiring managers, that puts more weight on the quality of the original hiring decision. Clear role expectations, structured onboarding and a considered probation process become more important, and so does a thorough assessment at shortlist and interview stage. In a market where specialist talent is scarce and a rushed appointment is tempting, it is a useful prompt to slow down where it counts.

October 2027 will bring pregnancy protections and flexible working

The Government has committed to introducing enhanced dismissal protections for pregnant women and new mothers from October 2027. The same month brings a reasonableness test for flexible working requests, which is expected to make it harder for employers to refuse them without a sound business reason.

Life sciences roles often combine travel, field-based work and hybrid patterns, from MSLs and clinical research associates to commercial and market access teams. Employers who have a clear, consistently applied position on flexibility will be better placed than those handling requests case by case. Candidates are also likely to raise the subject earlier in the process, so hiring managers should be ready to discuss it openly.

Pay transparency is heading towards job adverts

Pay is one of the busiest areas on the agenda. Sessions will look at the consultation on reforming the equal pay framework, including proposals for a new enforcement unit and extending protections to race and disability, alongside the shift to mandatory gender pay gap action plans. A ‘say what you pay’ requirement for job adverts is also under discussion, although the timeline for legislation has not been set.

For hiring managers, the practical point is preparation. Salary ranges across similar roles in life sciences can vary widely, particularly between large pharma, early-stage biotech and consultancies. Being able to define a justified range at the briefing stage, and to check it against the pay of existing team members, will matter far more if ranges become public. Pay equity in outsourcing arrangements is also on the agenda, which may be relevant to organisations that rely on interim and contract talent.

Harassment duties and external-facing roles

Strengthened duties on sexual harassment, including harassment by third parties, have been in force since October 2026. The conference will examine what taking ‘all reasonable steps’ looks like in practice, with particular attention to customer-facing roles and confidence in reporting routes.

Many life sciences roles involve regular external engagement with healthcare professionals, investigators, hospital sites and congress delegates. Employers in this space will need to consider how those settings are covered by their policies, training and reporting processes. Candidates, in turn, are becoming more likely to ask how an organisation supports its people when something goes wrong.

Women’s health, retention and progression

Another strand of the agenda covers women’s health at work. Menopause action plans are becoming mandatory, and discussion will consider what meaningful support looks like beyond minimum compliance, including occupational health, return to work after ill-health and bereavement leave that covers pregnancy loss before 24 weeks.

On progression, sessions will look at sponsorship pipelines, succession planning and the pace of movement into executive roles, along with representation in STEM and digital roles. For life sciences employers competing for experienced people, retention is part of the hiring strategy. A credible approach to health, flexibility and progression is increasingly part of what candidates weigh when comparing offers.

What about guaranteed hours?

The conference will also consider new rights to guaranteed hours, notice of shifts and payment for short-notice changes. These are most relevant to lower-hours and zero-hours arrangements, which are less common in specialist life sciences hiring. It is also worth noting that recent updates to the Government’s timetable have not confirmed an implementation date for these measures, so employers should treat the timing as open.

What does this mean for life sciences hiring and the job market?

The agenda is wide-ranging, but the themes are consistent:

• Hiring decisions carry more weight when the dismissal qualifying period falls to six months.
• Pay ranges may need to stand up to public scrutiny, so job evaluation and internal parity are worth reviewing now.
• A clear flexible working position is becoming part of the employer proposition, particularly ahead of October 2027.
• Harassment prevention needs to cover external-facing and field-based roles, not only the office.
• Women’s health support, return to work and progression pathways are increasingly part of how candidates compare employers.

For the recruitment industry, the shift is towards earlier and more detailed conversations. Briefings are likely to cover pay bands, flexibility and policy in more depth, and candidates will arrive better informed about their rights and expectations. Recruiters are not legal advisers, and employers should take specialist advice on their own obligations, but we can help hiring managers understand how the market is likely to respond.

Much will depend on how the Government finalises the detail and timetable. The question for life sciences employers is whether they will be ready when it does.

Carrot specialises exclusively in Pharma, Biotech and MedTech, with expertise spanning a wide range of specialist functions across these industries.

We support clients with contingent recruitment solutions for mid to senior-level talent, across both permanent and interim appointments. Our specialist market knowledge, extensive network and sector-focused approach enable us to connect organisations with the talent they need to grow.

If you are building or expanding a team and want to talk through what these changes mean for your hiring plans, get in touch.

Looking for your next role in Life Sciences? 

Louise Lavelle

Associate Director